Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Herrmann

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Muscle & Nerve|July 22, 2014
Prospective study of muscle cramps in Charcot-Marie-tooth diseaseNicholas E Johnson, Janet Sowden, Nuran Dilek, et al.
Muscle & Nerve|September 1, 2010
Broadening the spectrum of controls for skin biopsy in painful neuropathiesDavid N Herrmann, Alec B O'Connor, Steven R Schwid, et al.
Muscle & Nerve|May 30, 2013
Electrodiagnosis of ulnar neuropathy at the elbow (Une): a Bayesian approachEric L Logigian, Raissa Villanueva, Paul T Twydell, et al.
Pain Medicine (Malden, Mass.)|January 17, 2015
Exploring the role of tanezumab as a novel treatment for the relief of neuropathic painCandace Bramson, David N Herrmann, William Carey, et al.
Annals of Neurology|March 9, 2023
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate EndpointsMary M Reilly, David N Herrmann, Davide Pareyson, et al.
Neuromuscular Disorders : NMD|August 6, 2014
Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspectiveNicholas E Johnson, Chad R Heatwole, Nuran Dilek, et al.
Journal of the Peripheral Nervous System : JPNS|June 4, 2023
Recruiting for an International Rare Disease Clinical Trial Readiness Study during the COVID-19 pandemic: Challenges and solutionsKaty Eichinger, Steffen Behrens-Spraggins, Janet E Sowden, et al.
Journal of the Neurological Sciences|December 22, 2019
Is folate deficiency a common cause of distal symmetric polyneuropathy in Zambian clinics?Michelle Kvalsund, Violet Kayamba, Paul Kelly, et al.
Neurology|September 21, 2018
The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM)Katy Eichinger, Joshua Burns, Kayla Cornett, et al.
Journal of the Neurological Sciences|July 31, 2014
Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatmentMark T Brown, David N Herrmann, Mark Goldstein, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Muscle & Nerve|July 22, 2014
Prospective study of muscle cramps in Charcot-Marie-tooth diseaseNicholas E Johnson, Janet Sowden, Nuran Dilek, et al.
Muscle & Nerve|September 1, 2010
Broadening the spectrum of controls for skin biopsy in painful neuropathiesDavid N Herrmann, Alec B O'Connor, Steven R Schwid, et al.
Muscle & Nerve|May 30, 2013
Electrodiagnosis of ulnar neuropathy at the elbow (Une): a Bayesian approachEric L Logigian, Raissa Villanueva, Paul T Twydell, et al.
Pain Medicine (Malden, Mass.)|January 17, 2015
Exploring the role of tanezumab as a novel treatment for the relief of neuropathic painCandace Bramson, David N Herrmann, William Carey, et al.
Annals of Neurology|March 9, 2023
Trials for Slowly Progressive Neurogenetic Diseases Need Surrogate EndpointsMary M Reilly, David N Herrmann, Davide Pareyson, et al.
Neuromuscular Disorders : NMD|August 6, 2014
Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspectiveNicholas E Johnson, Chad R Heatwole, Nuran Dilek, et al.
Journal of the Peripheral Nervous System : JPNS|June 4, 2023
Recruiting for an International Rare Disease Clinical Trial Readiness Study during the COVID-19 pandemic: Challenges and solutionsKaty Eichinger, Steffen Behrens-Spraggins, Janet E Sowden, et al.
Journal of the Neurological Sciences|December 22, 2019
Is folate deficiency a common cause of distal symmetric polyneuropathy in Zambian clinics?Michelle Kvalsund, Violet Kayamba, Paul Kelly, et al.
Neurology|September 21, 2018
The Charcot-Marie-Tooth Functional Outcome Measure (CMT-FOM)Katy Eichinger, Joshua Burns, Kayla Cornett, et al.
Journal of the Neurological Sciences|July 31, 2014
Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatmentMark T Brown, David N Herrmann, Mark Goldstein, et al.
Pageof 13